Serum uromodulin (sUmod) represents a promising biomarker for acute kidney injury (AKI) in COVID-19 patients, as reported in a published collaborative study between EUROIMMUN, St Georg Hospital (Leipzig, Germany) and further institutes and clinics. AKI is a frequent complication in patients hospitalized with COVID-19 and is associated with an increased risk of fatal outcomes. Early […]
With passion for rheumatology! Systemic autoimmune rheumatic diseases encompass a wide range of different inflammatory joint, tissue and vascular diseases, such as rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis. They are diagnosed on the clinical history, imaging techniques, and serological tests. Antibody detection is a useful diagnostic tool and can provide essential information for
Autoantibodies targeting the protein RGS8 (regulator of G-protein signaling 8) are associated with a particular subtype of Hodgkin’s lymphoma, as described in a recently published study performed in a collaboration between EUROIMMUN and research institutes in France, Spain and USA. The novel autoantibodies are suggested to be of at least intermediate risk for paraneoplastic neurological
EUROIMMUN chemiluminescence immunoassays (ChLIA) for Alzheimer’s disease (AD) biomarkers provide reliable analytical and clinical performance, as demonstrated in two newly published studies performed in a collaboration between researchers at EUROIMMUN and the Memory Clinic of the University Hospital Magdeburg, Germany. Measurement of the four core biomarkers beta-amyloid (Aβ) 1-40, Aβ1-42, total tau and tau phosphorylated
A novel cell-based immunofluorescence assay (CBA) provides sensitive and specific detection of IgM antibodies against myelin-associated glycoprotein (MAG), as demonstrated in a study published in collaboration with scientists from the University of Verona and the Pediatric Research Institute in Padua, Italy. The Anti-MAG CBA is now available for research use*. Anti-MAG-IgM antibodies are markers for
